id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
biomedich-767	Rahayu, Ani; Sari, Dwi Puspita; Ningsih, Lukluk Utami; Fatimah, A. Triwildan ST	Cost Effectiveness Analysis of Favipiravir and Oseltamivir Antiretroviral Covid-19 Patients in Bogor Cisarua Lung Hospital	2025	6	.pdf	application/pdf	3139	160	48	For acute COVID-19 conditions and molecular detection methods, NAAT (Nucleid Acid Amplification Test) examinations, including RT-PCR examinations of COVID-19 patients who are hospitalized, show positive results for antivirals such as chloroquinphosphate, hydroxychloroquine, Favipiravir, Oseltamivir, remdesivir, and combinations between lopinavir and ritonavir (Suresh Kumar VC et al. 2020, Di Gennaro F et al. 2020) Study results show that oseltamivir is not effective against SARSCOV-2 in both in vitro testing and case reports in COVID-19 patients (Uyeki TM 2018).	cache/biomedich-767.pdf	txt/biomedich-767.txt